Cefaclor

CAS 70356-03-5 5 current records 9 historicalSmall Molecule

Who holds supplier records for Cefaclor? 5 organisations hold a current record for Cefaclor: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), China (2) and Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cefaclor: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cefaclor

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cefaclor. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • ACS DOBFAR SPA
    Active DMF 13780 · latest filing Sept 1998
    ItalyCEP Company GMP cert on record
  • Lupin Limited
    Inactive DMF 13217 · latest filing Apr 1998
    IndiaCEP Company GMP cert on record
  • Qilu Antibiotics Pharmaceutical Co., Ltd.
    ChinaCEP Company GMP cert on record
  • IndiaCEP Company GMP cert on record
  • ZHEJIANG DONGBANG PHARMACEUTICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Cefaclor sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (5)

Certificates of Suitability on the EDQM register for Cefaclor, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
Qilu Antibiotics Pharmaceutical Co., Ltd. JinanCN
CEP 2018-052 - Rev 01
Cefaclor
Feb 2025Inspected Jun 2026
Austria
ZHEJIANG DONGBANG PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2022-222 - Rev 00
Cefaclor
Nov 2024—
ACS DOBFAR S.P.A. TribianoIT
CEP 2023-429 - Rev 00
Cefaclor, Enzymatic
May 2024—
LUPIN LIMITED MumbaiIN
R1-CEP 2001-359 - Rev 05
Cefaclor
Jun 2018—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
R1-CEP 1997-027 - Rev 08
Cefaclor
May 2015—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (9)

Organisations whose Type II DMFs for Cefaclor are no longer active. These show a past filing, not current supply.

Show all 9 historical records
  • Kyongbo Pharmaceutical Co., Ltd.
    South · Inactive DMF 20288 · filed Nov 2006
  • India · Inactive DMF 19643 · filed Jul 2006
  • USA · Inactive DMF 14605 · filed Nov 1999
  • RANBAXY LABORATORIES LTD
    Inactive DMF 13790 · filed Sept 1998
  • United States · Inactive DMF 13598, 13622 · filed Sept 1998
  • DISTA PRODUCTS CO DIV ELI LILLY AND CO
    Inactive DMF 13647 · filed Sept 1998
  • MIWON
    Inactive DMF 13226 · filed Apr 1998
  • USA · Inactive DMF 13218 · filed Apr 1998
  • South Korea · Inactive DMF 14211 · filed Apr 1997

Overview

Cefaclor is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201018).

Chemical identity

IUPAC name
(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate
Canonical SMILES
C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)Cl.O
InChIKey
WKJGTOYAEQDNIA-IOOZKYRYSA-N
Synonyms
Bacticlor mr, Ceclor, Ceclor cd, Cefaclor, Cefaclor monohydrate, COMPOUND 99638, COMPOUND-99638, Distaclor, Distaclor mr, J01DC04, Keftid, NSC-757422

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cephalosporin Antibacterial
Chemical structure
Cephalosporins

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cefaclor?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Cefaclor: ACS DOBFAR SPA (Italy), Lupin Limited (India), Qilu Antibiotics Pharmaceutical Co., Ltd. (China), Sun Pharmaceutical Industries Limited (India) and ZHEJIANG DONGBANG PHARMACEUTICAL CO., LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cefaclor Drug Master Files are active?

ACS DOBFAR SPA (DMF 13780). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cefaclor records mean?

9 organisations have only inactive Type II DMFs for Cefaclor. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Cefaclor have a European Certificate of Suitability?

Yes. 5 organisations hold a valid CEP for Cefaclor on the EDQM register, including Qilu Antibiotics Pharmaceutical Co., Ltd. Jinan (CN), ZHEJIANG DONGBANG PHARMACEUTICAL CO., LTD. Taizhou (CN), ACS DOBFAR S.P.A. Tribiano (IT), LUPIN LIMITED Mumbai (IN) and SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Cefaclor supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cefaclor?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.